MAPK3 antibody (Mitogen-Activated Protein Kinase 3)

Details for Product anti-MAPK3 Antibody No. ABIN6663371
Antigen
  • ERK-1
  • ERK1
  • ERT2
  • HS44KDAP
  • HUMKER1A
  • P44ERK1
  • P44MAPK
  • PRKM3
  • p44-ERK1
  • p44-MAPK
  • Erk-1
  • Erk1
  • Ert2
  • Esrk1
  • Mnk1
  • Mtap2k
  • Prkm3
  • p44
  • p44erk1
  • p44mapk
  • fi06b09
  • wu:fi06b09
  • zERK1
  • Tb08.10J17.940
  • MAPK1
  • MNK1
  • ATMAPK3
  • ATMPK3
  • T6D9.4
  • mitogen-activated protein kinase 3
  • mitogen-activated protein kinase 3
  • mitogen activated protein kinase 3
  • mitogen-activated serine/threonine-protein kinase
  • MAPK3
  • Mapk3
  • mapk3
  • Tc00.1047053509475.10
  • Tb927.8.3550
  • CEK1
  • MPK3
Alternatives
anti-Human MAPK3 antibody for Immunohistochemistry (Paraffin-embedded Sections)
Reactivity
Human
549
314
294
57
47
44
44
29
19
18
16
10
10
9
9
8
7
4
3
2
2
1
1
1
Host
Mouse
437
114
19
6
1
Clonality
Monoclonal
Conjugate
This MAPK3 antibody is un-conjugated
35
26
25
15
14
14
9
9
9
9
9
9
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
Application
Western Blotting (WB)
438
203
198
95
71
71
56
42
39
35
19
14
8
4
3
2
1
1
1
Options
Immunogen Synthetic Peptide
Cross-Reactivity Human, Mouse (Murine)
Plasmids, Primers & others Plasmids, Primers & others MAPK3 products on genomics-online (e.g. as negative or positive controls)
Antigen
Alternative Name MAPK3 (MAPK3 Antibody Abstract)
Molecular Weight 44kDa
Gene ID 5595
UniProt P27361
Pathways MAPK Signaling, RTK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGFR1 Specific Signals
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Product cited in: Wu, Qin, Guo, Li, Chen: "AKT/ERK activation is associated with gastric cancer cell resistance to paclitaxel." in: International journal of clinical and experimental pathology, Vol. 7, Issue 4, pp. 1449-58, 2015 (PubMed). Method employed by authors: Western Blotting (WB)

Yang, Li, Liu, Yuan, Lu, Chen, Zhao: "RNA-seq reveals determinants of sensitivity to chemotherapy drugs in esophageal carcinoma cells." in: International journal of clinical and experimental pathology, Vol. 7, Issue 4, pp. 1524-33, 2015 (PubMed). Method employed by authors: Western Blotting (WB)

Fan, Zhang, Hu, Li, Zhang: "Activation of AKT/ERK confers non-small cell lung cancer cells resistance to vinorelbine." in: International journal of clinical and experimental pathology, Vol. 7, Issue 1, pp. 134-43, 2014 (PubMed). Method employed by authors: Western Blotting (WB)

Xu, Shi, Chen, Sun, Wu, Wang, Wang: "Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell." in: International journal of clinical and experimental pathology, Vol. 6, Issue 12, pp. 2745-56, 2014 (PubMed). Method employed by authors: Western Blotting (WB)

Yang, Xu, Shen, Zhu, Li, He, Chen, Wang, Shi, Ji: "Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine." in: International journal of clinical and experimental pathology, Vol. 7, Issue 2, pp. 521-8, 2014 (PubMed). Method employed by authors: Western Blotting (WB)

Did you look for something else?